Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

PURPOSE: This multicenter study, to our knowledge, is the first phase III trial to compare trabectedin versus dacarbazine in patients with advanced liposarcoma or leiomyosarcoma after prior therapy with an anthracycline and at least one additional systemic regimen. PATIENTS AND METHODS: Patients wer...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Clin Oncol
Κύριοι συγγραφείς: Demetri, George D., von Mehren, Margaret, Jones, Robin L., Hensley, Martee L., Schuetze, Scott M., Staddon, Arthur, Milhem, Mohammed, Elias, Anthony, Ganjoo, Kristen, Tawbi, Hussein, Van Tine, Brian A., Spira, Alexander, Dean, Andrew, Khokhar, Nushmia Z., Park, Youn Choi, Knoblauch, Roland E., Parekh, Trilok V., Maki, Robert G., Patel, Shreyaskumar R.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2016
Θέματα:
ORIGINAL REPORTS
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070559/
https://ncbi.nlm.nih.gov/pubmed/26371143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.4734
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια